The MR vaccine of Indian Immunologicals is the outcome of Indo-Vietnam partnership, wherein IIL has partnered with Center for Research and Production of Vaccines and Biologicals, also called Polyvac in Vietnam
Hyderabad: A 30-year-old male patient from Hyderabad, who was suffering from Avascular Necrosis (AVN), a medical condition that causes death of bone tissue due to lack of blood supply leading to tiny breaks and bone collapse, received treatment for his medical condition from senior orthopaedic surgeon at Apollo Hospitals, Hyderabad, Dr K J Reddy, a […]
Hyderabad: Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday. Corbevax , India’s […]
The nasal vaccine is different from the two intramuscular vaccines which recently got approval, due to being non-invasive, needle-free, not requiring trained healthcare workers, eliminating needle-associated risks, and suitable for children and adults, having scalable manufacturing.
The vaccine candidate includes an antigen in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialisation team, along with Dynavax’s advanced adjuvant CpG 1018.